Osteosarcoma Institute

Organization Overview

Osteosarcoma Institute is located in Dallas, TX. The organization was established in 2018. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. As of 12/2023, Osteosarcoma Institute employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Osteosarcoma Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2023, Osteosarcoma Institute generated $1.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (27.3%) each year. All expenses for the organization totaled $2.7m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.

Since 2020, Osteosarcoma Institute has awarded 31 individual grants totaling $4,800,449. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2023

Describe the Organization's Mission:

Part 3 - Line 1

THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.

Describe the Organization's Program Activity:

Part 3 - Line 4a

THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $500,000 WITH EMORY UNIVERSITY. $250,000 OF THIS WAS FUNDED IN 2023.


THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND A TOTAL OF $560,000 FOR CORRELATIVE STUDY AND TRANSLATIONAL SCIENCE GRANT WITH THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. $200,000 OF THIS WAS FUNDED IN 2023.


THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND TWO GRANTS FOR A TOTAL OF $1,300,000 FOR A CLINICAL TRIAL AND CORRELATIVE STUDY WITH THE DANA FARBER CANCER INSTITUTE. $355,000 OF THIS WAS FUNDED IN 2023.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$1,258,050
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$1,258,050
Total Program Service Revenue$0
Investment income $111,384
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $1,369,434

Grants Awarded

Over the last fiscal year, Osteosarcoma Institute has awarded $1,424,320 in support to 10 organizations.

Grant RecipientAmount

THE UNIVERSITY OF TEXAS - MD ANDERSON CANCER CENTER

PURPOSE: CLINICAL TRIAL GRANT

$124,314

DANA FARBER CANCER INSTITUTE

PURPOSE: CLINICAL TRIAL AND CORRELATIVE RESEARCH GRANTS

$355,000

REGENTS OF THE UNIVERSITY OF FLORIDA

PURPOSE: CORRELATIVE STUDIES

$100,000

REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO

PURPOSE: TRANSLATIONAL RESEARCH GRANTS

$200,000

RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL

PURPOSE: TRANSLATIONAL RESEARCH GRANTS

$124,800

REGENTS OF EMORY UNIVERSITY

PURPOSE: TRANSLATIONAL RESEARCH GRANTS

$250,000
View Grant Profile

Create an account to unlock the data you need.

or